Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. - Wikidata - wikimedia - TriplyDB

Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.

Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.

http://www.wikidata.org/entity/Q34231924

about

Inhibition of microRNA function by antimiR oligonucleotides Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling MicroRNAs in lipid metabolism Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis 'Micro-managers' of hepatic lipid metabolism and NAFLD The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport MicroRNA modulation of cholesterol homeostasis Post-transcriptional regulation in metabolic diseases Novel concepts in HDL pharmacology.SREBF and miR33 in cholesterol and lipid homeostasis Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment MicroRNAs in metabolism and metabolic disorders Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP.Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer protein MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo MicroRNA-management of lipoprotein homeostasis.Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33 Development of microRNA therapeutics is coming of age.Interplay of mitochondrial metabolism and microRNAs.Identification of conserved and novel microRNAs in the Pacific oyster Crassostrea gigas by deep sequencing MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report.Non-coding RNAs and lipid metabolism Effects of hypoxic exercise training on microRNA expression and lipid metabolism in obese rat livers.MicroRNAs in cardiometabolic disease.microRNAs and HDL life cycle.Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways MicroRNAs and lipoproteins: a connection beyond atherosclerosis?Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice microRNAs and cancer metabolism reprogramming: the paradigm of metformin Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.Growth hormone-regulated mRNAs and miRNAs in chicken hepatocytes Comparative microRNA expression profiles of cynomolgus monkeys, rat, and human reveal that mir-182 is involved in T2D pathogenic processes MicroRNAs: a connection between cholesterol metabolism and neurodegeneration.

P2860

Q21198757-CCB15F35-3897-4D62-9854-FE577BC553C1 Q21245693-4210715B-9806-48F0-B3AE-274D9182E90F Q24601263-98C414A2-A7E6-4952-92FE-18F79BC765F7 Q24627398-523A48F7-589B-48D0-BDF0-853FAF582DCD Q24633633-A96912EB-52F4-4602-B8DB-BA97E728034F Q24634165-6CB599D5-6FBB-4ED4-8B7D-33359C91C9E6 Q26801228-D84FC968-1414-403F-A8F9-F2AEDF89F105 Q26801471-1DA3FFC6-4BB1-4E17-A317-DAF8B8C959B9 Q26997647-BF6DF0EA-F298-482E-9060-638F2EC9E63E Q27026071-2C4B8DAD-F742-41B2-A9E8-AE2FBDA2F8AE Q27028039-B5368C8F-0676-43E2-955C-507DDC84E536 Q27692691-DDD8E7E6-D5BF-48B9-8BCC-79F0151267C3 Q30230779-8004C9E5-2DBC-48E5-A3BC-52B2C2DA2F54 Q33567332-D6445676-7DB2-4F74-8125-EA20E54C7927 Q33607587-A71CB99F-4D31-4D7A-9446-7A67970771F0 Q33612997-EAAEE6AA-C00B-4BEE-9C02-C6B81139B1C3 Q33661920-046578F3-195A-4B44-AE3A-D54C0AD9DBC0 Q33672543-E3EDD001-118A-468B-B241-0E4FD1DAC84D Q33705462-9E284D0D-BF3D-4DCE-8E88-B9EF8C926564 Q33760162-5ADC00C6-5920-415F-A05C-9040B6BD4D54 Q33851062-66E216E9-CE80-4677-A2FE-4ECA101FAE82 Q33940346-BC7F62DD-8292-4DB4-AB3D-888466CDE959 Q33991443-FBF4953D-2839-45C2-85BB-A14C1251B6C1 Q34047312-7DA472A5-9B34-47AD-B12A-A3ADF2260A3F Q34066254-7AF79728-BB4D-4A0F-982E-F504D7CE02BF Q34093118-30998377-FCA0-42BD-AC5B-2EB66BC80BE4 Q34148844-540164FB-D751-48BA-8A0E-950EEB9891A1 Q34158382-FE7D0BAE-ED4C-4708-B187-71B0C2877281 Q34173988-E59945B2-01DE-4756-90DC-02A573E30B9C Q34175509-FF7F5F6D-243E-49DD-95DB-2CB34E560E40 Q34248289-52C5DA48-2C61-407B-B3A2-601EC37FE775 Q34271240-0B7A7799-DFDD-4FCE-A8C1-1326BBCD9D0F Q34311637-5953D3E3-4F47-4611-BD7C-8E341D57D8B7 Q34321706-8C1C362B-BD0A-4CAB-9C50-973C70051A32 Q34342477-356408F1-240F-4243-A5AF-68BDADF76908 Q34357915-DDE7608C-2E50-47D6-B239-F9894F8F9AA4 Q34426839-F2E573B1-577A-4815-96C0-B6CA48EE1AB0 Q34490199-D497D3FE-40FA-43FC-8AFF-66BC72BC21A6 Q34532789-DC267CF4-CC43-44AF-BFB3-EA7018B5486A Q34613640-31C4324E-0348-4D1E-B32E-8E13F202C1E2

P2860

Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.

http://www.wikidata.org/entity/Q34231924

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Expression of miR-33 from an S ...... port and fatty acid oxidation.

@ast

Expression of miR-33 from an S ...... port and fatty acid oxidation.

@en

Expression of miR-33 from an S ...... port and fatty acid oxidation.

@nl

type

label

Expression of miR-33 from an S ...... port and fatty acid oxidation.

@ast

Expression of miR-33 from an S ...... port and fatty acid oxidation.

@en

Expression of miR-33 from an S ...... port and fatty acid oxidation.

@nl

prefLabel

Expression of miR-33 from an S ...... port and fatty acid oxidation.

@ast

Expression of miR-33 from an S ...... port and fatty acid oxidation.

@en

Expression of miR-33 from an S ...... port and fatty acid oxidation.

@nl

P1433

Q34231924-188B8224-2C06-4340-9F4C-960F211D25C7

P1476

Q34231924-CA5E54E8-3E2F-4AFC-ADE5-9837C2AB01C7

P2093

Q34231924-016E0708-D56C-44F3-9561-E7354112E8B6

Q34231924-BBD2B38F-BBA8-4D70-ABC2-FC9DC68A4E4D

Q34231924-BF996430-8A6E-4BC8-8F51-3C52ECC07BC6

Q34231924-D694B95B-9FF6-4509-932C-22982657C5A3

Q34231924-EBB833FB-9C79-4982-956A-3E7815AA60D0

P2860

Q34231924-02DBA729-C2A1-41FF-8C4A-0CD43BC48BCA

Q34231924-038F3B81-3E78-4AE2-B83A-7778B21BB116

Q34231924-0C8E6E4D-1E11-47CC-899A-403EABD5A8A7

Q34231924-12B8A852-B8EC-4CD3-9CD7-1BC2BE5DF67E

Q34231924-135353FD-DC83-4C38-8DB8-3C1CB9D6CD70

Q34231924-1843B6B8-3FED-42C7-B0BC-A8FE448D60CC

Q34231924-18D872C1-CE33-44B9-B5ED-EB233AAF69DC

Q34231924-1BBF250C-2E06-4DB2-90E6-C58D14631C4B

Q34231924-1D7C2E4B-A3A6-4F25-B65F-1EDF9C37BCE1

Q34231924-24D2DF47-1D0B-4260-BB8F-55AEC324C146

P304

Q34231924-5AFDD43C-5A15-4A39-B4EC-CB9DAF35F9DA

P31

Q34231924-818E9D86-0FA5-4EE7-B9A1-511C709AA010

P356

Q34231924-4CAB868F-848B-4D30-9C8E-A744F89C4D12

P407

Q34231924-5959F320-DDD0-45CE-8B01-DA94CB6FA391

P433

Q34231924-13964AE0-D96C-46A3-A8C7-645E4F21A90B

P478

Q34231924-A2E1371D-169B-4759-91C2-9F47D3149780

P50

Q34231924-0D82B9EE-8678-4ED8-86BB-78D3EB351B2A

Q34231924-4ECF49D3-F6CF-470A-92FD-3A983F157EB7

Q34231924-A70A11E9-A6B7-4C32-967D-75CABF369177

Q34231924-DBAFE762-1EE6-48C7-8DE6-822B963354AE

P577

Q34231924-7E153C98-AE34-41E3-A682-2A0E4CF0C5A7

P698

Q34231924-F5396779-8127-4C6D-AB34-31E0C2DD7876

P921

Q34231924-C617FE9C-F982-4CB4-B932-1DBD59352736

P932

Q34231924-7FAB1088-9E36-4739-AE6C-7569FBCEF915

P356

JBC.M110.152090

P1433

Journal of Biological Chemistry

P1476

Expression of miR-33 from an S ...... port and fatty acid oxidation.

@en

P2093

Isabelle A Leclercq

http://www.w3.org/2001/XMLSchema#string

Isabelle Gerin

http://www.w3.org/2001/XMLSchema#string

Laure-Alix Clerbaux

http://www.w3.org/2001/XMLSchema#string

Nicolas Lanthier

http://www.w3.org/2001/XMLSchema#string

Olivier Haumont

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate microRNA target prediction correlates with protein repression levels

Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells

MicroRNA targeting specificity in mammals: determinants beyond seed pairing

MicroRNAs: target recognition and regulatory functions

MicroRNA-338-3p and microRNA-451 contribute to the formation of basolateral polarity in epithelial cells

The impact of microRNAs on protein output

Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites

Deadenylation is a widespread effect of miRNA regulation

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha

A simple method for the isolation and purification of total lipides from animal tissues

P304

33652-33661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.152090

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P50

Charles F. Burant

Ormond Macdougald

P577

2010-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20732877

http://www.w3.org/2001/XMLSchema#string

P921

P932

2962463

http://www.w3.org/2001/XMLSchema#string